These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7751583)

  • 1. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy.
    Guéchot J; Loria A; Serfaty L; Giral P; Giboudeau J; Poupon R
    J Hepatol; 1995 Jan; 22(1):22-6. PubMed ID: 7751583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hyaluronic acid reflects the effect of interferon treatment on hepatic fibrosis in patients with chronic hepatitis C.
    Yamada M; Fukuda Y; Koyama Y; Nakano I; Urano F; Katano Y; Hayakawa T
    J Gastroenterol Hepatol; 1996 Jul; 11(7):646-51. PubMed ID: 8840240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha.
    Lebensztejn DM; Sobaniec-Lotowska ME; Kaczmarski M; Voelker M; Schuppan D
    World J Gastroenterol; 2006 Jun; 12(21):3338-43. PubMed ID: 16733849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system.
    Ninomiya T; Yoon S; Hayashi Y; Sugano M; Kumon Y; Seo Y; Shimizu K; Kasuga M
    J Gastroenterol Hepatol; 1998 Jan; 13(1):68-74. PubMed ID: 9737575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of interferon-treated chronic hepatitis C and serum hepatic fibrosis markers.
    Ueno T; Ide T; Hashimoto O; Uchimura Y; Torimura T; Kumashiro R; Inuzuka S; Sata M
    Hepatogastroenterology; 2001; 48(40):1124-8. PubMed ID: 11490815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hyaluronan as a marker of liver fibrosis in hemophiliacs with hepatitis C virus-associated chronic liver disease.
    Yamada M; Fukuda Y; Nakano I; Katano Y; Takamatsu J; Hayakawa T
    Acta Haematol; 1998; 99(4):212-6. PubMed ID: 9644299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
    Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
    J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C.
    Ziol M; Nhieu JT; Roudot-Thoraval F; Métreau JM; Deugnier Y; Dhumeaux D; Zafrani ES
    J Hepatol; 1996 Dec; 25(6):833-41. PubMed ID: 9007710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B.
    Pontinha N; Pessegueiro H; Barros H
    Scand J Clin Lab Invest; 1999 Aug; 59(5):343-7. PubMed ID: 10533846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation.
    Manabe N; Chevallier M; Chossegros P; Causse X; Guerret S; Trépo C; Grimaud JA
    Hepatology; 1993 Dec; 18(6):1344-9. PubMed ID: 8244259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.
    Patel K; Lajoie A; Heaton S; Pianko S; Behling CA; Bylund D; Pockros PJ; Blatt LM; Conrad A; McHutchison JG
    J Gastroenterol Hepatol; 2003 Mar; 18(3):253-7. PubMed ID: 12603524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
    Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
    Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum hyaluronan in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Nishimura Y; Kawasaki H
    J Gastroenterol Hepatol; 1996 May; 11(5):459-65. PubMed ID: 8743918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection.
    Tsubota A; Kumada H; Chayama K; Arase Y; Saitoh S; Koida I; Suzuki Y; Kobayashi M; Murashima N; Ikeda K
    J Hepatol; 1997 Jul; 27(1):49-55. PubMed ID: 9252073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha.
    Hiramatsu N; Hayashi N; Kasahara A; Hagiwara H; Takehara T; Haruna Y; Naito M; Fusamoto H; Kamada T
    J Hepatol; 1995 Feb; 22(2):135-42. PubMed ID: 7790701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2A interferon.
    Gallorini A; Plebani M; Pontisso P; Chemello L; Masiero M; Mantovani G; Alberti A
    Liver; 1994 Oct; 14(5):257-64. PubMed ID: 7997085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis.
    Guéchot J; Serfaty L; Bonnand AM; Chazouillères O; Poupon RE; Poupon R
    J Hepatol; 2000 Mar; 32(3):447-52. PubMed ID: 10735615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
    Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
    J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum hyaluronan--a non-invasive test for diagnosing liver cirrhosis.
    Plevris JN; Haydon GH; Simpson KJ; Dawkes R; Ludlum CA; Harrison DJ; Hayes PC
    Eur J Gastroenterol Hepatol; 2000 Oct; 12(10):1121-7. PubMed ID: 11057458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.